Media Coverage header image

Media Coverage

Advanced Search
  • 09142023
    Westchester County Business Journal

    Stamford-based Americares is partnering with Quest Diagnostics to provide 10 clinics across the U.S. with no-cost diagnostic services for one year as a means of increasing access to care for low-income, uninsured and underinsured patients.

  • 09062023
    Patch.com

    Rutgers and Quest Diagnostics are expanding their collaboration to further improve access to critical primary care services for uninsured patients of the university’s Health Outreach Practice Experience (H.O.P.E.) Clinic in Plainfield. Resources from the Quest Diagnostics Foundation will enable the clinic to double its capacity by providing primary care services for a second day of the week.

  • 08312023
    Medical Device Network

    Quest Diagnostics has secured breakthrough device designation for its adeno-associated virus (AAV) test, AAVrh74 ELISA assay, from the US Food and Drug Administration (FDA). The test is an enzyme-linked immunosorbent in vitro diagnostic assay intended for the semi-quantitative detection of antibodies (IgG) to AAVrh74 capsid in the serum of humans. Quest also expanded collaboration with Sarepta to develop complementary diagnostics for Sarepta's gene therapies.

  • 08282023
    360Dx

    Researchers from Quest Diagnostics and collaborators have found that changes in levels of the cardiovascular risk marker free myeloperoxidase (MPO) appear correlated with an individual's overall mortality risk. The finding, described in a study published last month in PLOS One, indicate that longitudinal measurement of MPO could help physicians assess patients' mortality risk and response to interventions.

  • 08102023
    Urology Times

    Quest Diagnostics has partnered with Envision Sciences to commercially launch a novel prostate cancer biomarker test to help in identifying patients with more aggressive forms of the disease, Quest Diagnostics and the University of South Australia announced in separate news releases.1,2"Our goal for this innovative prostate biomarker test is to improve the accuracy of grading prostate cancer biopsies.

Show 5102550100 per page